The review by Rosemary J. Akhurst explores the role of Transforming Growth Factor β (TGF-β) in cancer and fibrosis, detailing its complex signaling mechanisms and therapeutic implications. TGF-β, through its signaling via types I and II receptors, exerts a wide range of effects on cell growth, differentiation, and homeostasis. Its role is dualistic; it suppresses tumor initiation but promotes progression in established tumors by enhancing invasion, metastasis, and immunosuppression. The review underscores the challenges and opportunities in targeting TGF-β signaling, highlighting various therapeutic strategies such as inhibitors, antibodies, and emerging drugs aiming to modulate this pathway for treating solid tumors.
The modulation of TGF-β signaling is critically relevant to Novastem's focus on stem cell therapies, particularly due to its role in cellular homeostasis and pathological states like cancer and fibrosis. TGF-β's impact on the tumor microenvironment and its role in promoting a stem cell-like phenotype in cancer cells could guide the development of stem cell therapies. These therapies might either aim to inhibit similar pathways to prevent undesirable angiogenesis and fibrosis or harness controlled TGF-β signaling to enhance the regenerative properties of stem cells in damaged tissues.
Dual Role in Cancer: TGF-β initially acts as a tumor suppressor but later promotes tumor growth and metastasis in established cancers.
Therapeutic Targeting: Various approaches to block TGF-β signaling are being explored, including receptor inhibitors and ligand-blocking antibodies, which aim to thwart its pro-tumorigenic effects.
Implications for Stem Cell Therapies: Insights from TGF-β's role in cancer can be applied to stem cell therapy, particularly in understanding how to manipulate these pathways to support tissue regeneration or inhibit harmful fibrosis.
The review by Rosemary J. Akhurst explores the role of Transforming Growth Factor β (TGF-β) in cancer and fibrosis, detailing its complex signaling mechanisms and therapeutic implications. TGF-β, through its signaling via types I and II receptors, exerts a wide range of effects on cell growth, differentiation, and homeostasis. Its role is dualistic; it suppresses tumor initiation but promotes progression in established tumors by enhancing invasion, metastasis, and immunosuppression. The review underscores the challenges and opportunities in targeting TGF-β signaling, highlighting various therapeutic strategies such as inhibitors, antibodies, and emerging drugs aiming to modulate this pathway for treating solid tumors.
The modulation of TGF-β signaling is critically relevant to Novastem's focus on stem cell therapies, particularly due to its role in cellular homeostasis and pathological states like cancer and fibrosis. TGF-β's impact on the tumor microenvironment and its role in promoting a stem cell-like phenotype in cancer cells could guide the development of stem cell therapies. These therapies might either aim to inhibit similar pathways to prevent undesirable angiogenesis and fibrosis or harness controlled TGF-β signaling to enhance the regenerative properties of stem cells in damaged tissues.
#TGFβ #CancerTherapy #StemCellTherapy #Novastem #Fibrosis #Metastasis #Immunosuppression #TherapeuticTargeting